Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms

Valsartan Improves  -Cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Metabolism: A randomized controlled trial

(2011) N. J. van der Zijl et al.   DIABETES CARE

Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans

(2011) D. H. van Raalte et al.   DIABETES CARE

Effects of renin–angiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet

(2010) Li Yuan et al.   ACTA DIABETOLOGICA

Effect of Renin-Angiotensin System Blockade on Insulin Resistance and Inflammatory Parameters in Patients With Impaired Glucose Tolerance

(2010) S. Pscherer et al.   DIABETES CARE

Valsartan Protects Pancreatic Islets and Adipose Tissue From the Inflammatory and Metabolic Consequences of a High-Fat Diet in Mice

(2010) Banumathi K. Cole et al.   HYPERTENSION

Telmisartan but not valsartan inhibits TGF-β-mediated accumulation of extracellular matrix via activation of PPARγ

(2010) Ying Yao et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Relationship Between A1C and Glucose Levels in the General Dutch Population: The New Hoorn Study

(2009) E. van 't Riet et al.   DIABETES CARE

Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide

(2009) Renate E. van Genugten et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action

(2009) E. J. Barrett et al.   DIABETOLOGIA

Blockade of the RAS increases Plasma Adiponectin in Subjects with Metabolic Syndrome and Enhances Differentiation and Adiponectin Expression of Human Preadipocytes

(2009) FS. Tian et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Angiotensin II Type 1 and Type 2 Receptors Regulate Basal Skeletal Muscle Microvascular Volume and Glucose Use

(2009) Weidong Chai et al.   HYPERTENSION

Effects of Antihypertensive Drugs on Capillary Rarefaction in Spontaneously Hypertensive Rats: Intravital Microscopy and Histologic Analysis

(2009) Bruno Sabino et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats

(2009) Damiano Rizzoni et al.   JOURNAL OF HYPERTENSION

Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats

(2009) Marina C Muñoz et al.   JOURNAL OF HYPERTENSION

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

(2009)   LANCET

Blockade of AT1 Receptor Improves Adipocyte Differentiation in Atherosclerotic and Diabetic Models

(2008) Y. Tomono et al.   AMERICAN JOURNAL OF HYPERTENSION

Impaired Tissue Perfusion

(2008) Bernard I. Levy et al.   CIRCULATION

Improved Early-Phase Insulin Response after Candesartan Treatment in Hypertensive Patients with Impaired Glucose Tolerance

(2008) Katsunori Suzuki et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Role of aldosterone and angiotensin II in insulin resistance: an update

(2008) Guido Lastra-Lastra et al.   CLINICAL ENDOCRINOLOGY

Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycemic Control

(2008) M. Mitsuishi et al.   DIABETES

Angiotensin inhibition stimulates PPARγ and the release of visfatin

(2008) A. Storka et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue

(2008) Mi H. Lee et al.   KIDNEY INTERNATIONAL

Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system

(2008) Atsuhito Saiki et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase

(2007) Yongzhong Wei et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance

(2007) Gijs H. Goossens   PHYSIOLOGY & BEHAVIOR